stability testing is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-01-08. Numbers and descriptions here follow the published literature rather than marketing material.
Hydrolysates are generally stable as dry powders but can absorb moisture and undergo browning during warm storage. The bitter taste of some hydrolysates arises from hydrophobic peptides exposed by cleavage, and it varies with enzyme choice and degree of hydrolysis. Reduced allergenicity is sometimes claimed, but residual IgE-binding peptides may remain, especially in partial hydrolysates. Regulatory frameworks treat extensively hydrolyzed and partially hydrolyzed products differently, and labeling rules vary by country. More research is needed on how specific peptide profiles relate to clinical outcomes.
Commercial production begins with whey protein concentrate or isolate dissolved in water. A protease is added under controlled pH and temperature, and the reaction is stopped by heat or pH adjustment once a target degree of hydrolysis is reached. Membrane filtration, often ultrafiltration or diafiltration, removes enzymes and small solutes while retaining peptides. The liquid is then concentrated and spray-dried into a powder. Each step influences peptide length, mineral content, and flavor.
Quality control for hydrolysates often includes allergen and contaminant checks. Because whey is a milk-derived ingredient, milk protein residues may remain, and the extent to which hydrolysis reduces allergenic potential is product-specific and not fully predictable. Tests may screen for heavy metals, melamine, pesticides, and microbial indicators. Enzyme residues and processing aids are also monitored when regulations require it. Batch-to-batch consistency is assessed through peptide mapping or functional tests, since small process changes can alter taste, solubility, or nutritional performance.
Laboratories characterize whey protein hydrolysate by several complementary methods. Total nitrogen or Kjeldahl analysis estimates crude protein, while amino acid analysis gives a more detailed composition. Size-exclusion chromatography and mass spectrometry separate peptides by molecular weight and can reveal the distribution of chain lengths. Degree of hydrolysis is often calculated from free amino groups using trinitrobenzenesulfonic acid or o-phthaldialdehyde assays. No single measurement captures all relevant properties, so specifications usually combine protein content, peptide profile, moisture, ash, and microbial limits.
| Property | Value | Notes |
|---|---|---|
| Degree of hydrolysis | Typically 5–35% | Higher values indicate more extensive peptide bond cleavage; ranges vary by product |
| Peptide molecular weight | Often 200–10,000 Da | Distribution depends on enzyme and reaction time |
| Moisture content | Usually below 6% | Low moisture supports powder stability and flow |
| pH (5% solution) | 6.0–7.5 | Value depends on starting material and neutralization steps |
| Microbiological test | Total plate count and coliforms | Used to verify hygiene during processing and packaging |
Regulatory status differs by country and intended use. In many jurisdictions, whey protein hydrolysate is regulated as a food ingredient, while specific infant formula or medical food uses may require additional review. Labeling rules govern protein content claims, allergen statements, and terms such as partially hydrolyzed or extensively hydrolyzed. Analytical methods for degree of hydrolysis are not fully standardized, so values can depend on the assay. This variability makes direct comparison between products difficult unless the method and reference material are stated.
Quality control for whey protein hydrolysate begins with specification of protein, moisture, ash, fat, lactose, and degree of hydrolysis, while molecular weight distribution is measured by size-exclusion chromatography or electrophoresis. Free amino acid content can be quantified by amino acid analysis. Microbial limits, heavy metals, and residual enzyme activity are also monitored. Because hydrolysis conditions influence batch consistency, manufacturers validate processes and test each lot against release criteria. Sampling plans and reference standards help compare results across laboratories.
Storage stability depends on moisture, temperature, oxygen, and packaging, and hydrolysates are hygroscopic and can cake when exposed to humid air. Maillard reactions between peptides and residual lactose can cause browning and flavor changes during warm storage, while lipid oxidation may develop if residual fat is present. Cool, dry conditions and sealed containers slow these reactions. Shelf-life studies typically monitor moisture, color, solubility, molecular weight profile, and microbial counts over time. Accelerated tests estimate stability, but real-time data remain the reference for shelf-life assignment.
Dry hydrolysate powders are generally stable when kept cool, dry, and sealed, while moisture uptake can cause caking, Maillard browning, and loss of solubility. Higher temperatures accelerate these changes and may alter flavor. Recommended storage conditions often fall between 15 and 25 degrees Celsius with relative humidity below 60 percent. Once reconstituted, liquid hydrolysate solutions support microbial growth and may develop bitterness or haze over time. Packaging in moisture-barrier containers with desiccants helps maintain quality during transport and warehouse storage.
Quality control for hydrolysate ingredients focuses on identity, purity, and consistency, with specifications that may include total protein, hydrolysis level, molecular weight distribution, microbiological limits, heavy metals, and allergen labeling. In some jurisdictions, partially and extensively hydrolyzed formulas are regulated as foods for special dietary uses or as infant formula ingredients. Regulatory status varies by country and intended use. Documentation such as certificates of analysis, safety data sheets, and method validation records supports traceability. Open questions remain about standardizing hydrolysis measurements across suppliers and laboratories.
Testing hydrolysate powders typically begins with proximate analysis for moisture, ash, fat, and total nitrogen. Protein content is calculated from nitrogen using a conversion factor, most often Kjeldahl or Dumas combustion. Peptide size distribution is assessed by size-exclusion chromatography, reversed-phase HPLC, or mass spectrometry. Sodium dodecyl sulfate polyacrylamide gel electrophoresis can show residual intact protein bands. Free amino groups may be quantified by colorimetric assays to estimate cleavage extent, though different methods and laboratories are not always directly comparable.
Regulatory and labeling frameworks vary by country. In the United States, whey protein hydrolysate may be regulated as a food ingredient or a dietary supplement ingredient depending on intended use. In the European Union, it falls under general food law, with additional rules for infant formula and foods for special medical purposes. A claim of hypoallergenicity is not established by hydrolysis alone and generally requires clinical evidence. Open questions remain about how degree of hydrolysis relates to bitterness, nitrogen absorption, and residual allergenicity across different products and processing methods.
Quality control for whey protein hydrolysate combines compositional and molecular tests. Protein content is measured by Kjeldahl or Dumas nitrogen determination. Moisture, ash, fat, and lactose are checked with standard food methods. The degree of hydrolysis is estimated by TNBS, OPA, or pH-stat procedures that quantify free amino groups or released protons. Molecular weight distribution is examined by size-exclusion chromatography or SDS-PAGE. These tests describe average peptide size rather than exact peptide sequences, and results depend on standards and calibration.
Physical properties such as particle size, bulk density, and reconstitution behavior affect handling and finished product quality. Water activity and moisture content influence shelf life; high moisture can promote caking, browning, and microbial growth. Color is monitored because Maillard reactions between peptides and reducing sugars can darken the powder during storage. Taste panels and instrumental methods may assess bitterness, which is a common challenge for hydrolysates. Specifications often include limits for heavy metals, microbiological counts, and residual fat, depending on the intended market.
Quality control for hydrolyzed whey protein focuses on composition, peptide size, and batch consistency. Protein content is commonly measured by Kjeldahl or combustion analysis, while moisture and ash are determined by gravimetric methods. Peptide molecular weight distribution is often assessed by size exclusion chromatography or mass spectrometry. The extent of hydrolysis can be estimated by titration, trinitrobenzenesulfonic acid assays, or formol titration. Because hydrolysis produces a complex mixture, no single test captures every relevant property, and laboratories often combine several methods.
=== Protection === The lungs possess several characteristics which protect against infection. The respiratory tract is lined by respiratory epithelium or respiratory mucosa, with hair-like projections called cilia that beat rhythmically and carry mucus. This mucociliary clearance is an important defence system against air-borne infection. The dust particles and bacteria in the inhaled air are caught in the mucosal surface of the airways, and are moved up towards the pharynx by the rhythmic upward beating action of the cilia. The lining of the lung also secretes immunoglobulin A which protects against respiratory infections; goblet cells secrete mucus which also contains several antimicrobial compounds such as defensins, antiproteases, and antioxidants. The size of the respiratory tract and the flow of air also protect the lungs from larger particles. Smaller particles deposit in the mouth and behind the mouth in the oropharynx, and larger particles are trapped in nasal hair after inhalation.
Chevreul's scientific work covered a wide range, but he is best known for the classical researches he carried out on animal fats, published in 1823 (Recherches sur les corps gras d'origine animale). These enabled him to elucidate the true nature of soap; he was also able to discover the composition of stearin, a white substance found in the solid parts of most animal and vegetable fats, and olein, the liquid part of any fat, and to isolate stearic and oleic acids, the names of which he invented. This work led to important improvements in the processes of candle-manufacture. Chevreul was a determined enemy of charlatanism in every form, and a complete sceptic as to the "scientific" psychical research or spiritualism which had begun in his time. His research on the "magic pendulum", Dowsing rods and table-turning is revolutionary. In an open letter to André-Marie Ampère in 1833, and his 1854 paper "De la baguette", Chevreul explains how human muscular reactions, totally involuntary and subconscious, are responsible for seemingly magical movements. In the end, Chevreul discovered that once a person holding divining rods/magic pendulum became aware of the brain's reaction, the movements stopped and could not be willingly reproduced. His was one of the earliest explanations of the ideomotor effect.
Danny Gutwein, Professor of Jewish History at the University of Haifa, proposes a twist on an old idea, asserting that Sykes's February 1917 approach to the Zionists was the defining moment, and that it was consistent with the pursuit of the government's wider agenda to partition the Ottoman Empire.
A conjugated protein is a protein that functions in interaction with other (non-polypeptide) chemical groups attached by covalent bonding or weak interactions. These non-Protein components are essential for the proteins biological activity and are not made up of amino acids. Many proteins contain only amino acids and no other chemical groups, and they are called simple proteins. However, other kind of proteins yield, on hydrolysis, some other chemical component in addition to amino acids and they are called conjugated proteins. The non-amino part of a conjugated protein is usually called its prosthetic group, and it plays a crucial role in determining the protein's structure and function. Most prosthetic groups are formed from vitamins, however, they can vary widely in composition and may include molecules like carbohydrates, lipids, metal ion, or nucleic acids. Conjugated proteins are classified on the basis of the chemical nature of their prosthetic groups. This classification reflects the differences of their functions, which includes roles in transport, enzymatic activity, structural support, and cellular communication. Conjugated proteins are essential to many biological processes because of their combined protein and non-protein components.
In October 1969, Willy Brandt became chancellor. He maintained West Germany's close alignment with the United States and focused on strengthening European integration in western Europe, while launching the new policy of Ostpolitik aimed at improving relations with Eastern Europe. Brandt was controversial on both the right wing, for his Ostpolitik, and on the left wing, for his support of right-wing authoritarian regimes and of American policies, including the Vietnam War. The Brandt Report became a recognised measure for describing the general North-South divide in world economics and politics between an affluent North and a poor South. Brandt was also known for his fierce anti-communist policies at the domestic level, culminating in the Radikalenerlass (Anti-Radical Decree) in 1972. In 1970, while visiting a memorial to the Warsaw Ghetto Uprising crushed by the Germans, Brandt unexpectedly knelt and meditated in silence, a moment remembered as the Kniefall von Warschau. Brandt resigned as chancellor in 1974, after Günter Guillaume, one of his closest aides, was exposed as an agent of the Stasi, the East German secret service.
Sources: en.wikipedia.org
==== MeSH D12.776.377.715.548 – immunoglobulins ==== MeSH D12.776.377.715.548.114 – antibodies MeSH D12.776.377.715.548.114.071 – antibodies, anti-idiotypic MeSH D12.776.377.715.548.114.107 – antibodies, archaeal MeSH D12.776.377.715.548.114.125 – antibodies, bacterial MeSH D12.776.377.715.548.114.125.288 – antistreptolysin MeSH D12.776.377.715.548.114.134 – antibodies, bispecific MeSH D12.776.377.715.548.114.143 – antibodies, blocking MeSH D12.776.377.715.548.114.167 – antibodies, catalytic MeSH D12.776.377.715.548.114.179 – antibodies, fungal MeSH D12.776.377.715.548.114.185 – antibodies, helminth MeSH D12.776.377.715.548.114.191 – antibodies, heterophile MeSH D12.776.377.715.548.114.224 – antibodies, monoclonal MeSH D12.776.377.715.548.114.224.570 – muromonab-cd3 MeSH D12.776.377.715.548.114.240 – antibodies, neoplasm MeSH D12.776.377.715.548.114.248 – antibodies, phospho-specific MeSH D12.776.377.715.548.114.252 – antibodies, protozoan MeSH D12.776.377.715.548.114.254 – antibodies, viral MeSH D12.776.377.715.548.114.254.150 – deltaretrovirus antibodies MeSH D12.776.377.715.548.114.254.150.440 – hiv antibodies MeSH D12.776.377.715.548.114.254.150.500 – htlv-i antibodies MeSH D12.776.377.715.548.114.254.150.510 – htlv-ii antibodies MeSH D12.776.377.715.548.114.254.450 – hepatitis antibodies MeSH D12.776.377.715.548.114.254.450.251 – hepatitis a antibodies MeSH D12.776.377.715.548.114.254.450.504 – hepatitis b antibodies MeSH D12.776.377.715.548.114.254.450.510 – hepatitis c antibodies MeSH D12.776.377.715.548.114.257 – antigen-antibody complex MeSH D12.776.377.715.548.114.301 – antitoxins MeSH D12.776.377.715.548.114.301.138 – antivenins MeSH D12.776.377.715.548.114.301.268 – botulinum antitoxin MeSH D12.776.377.715.548.114.301.438 – diphtheria antitoxin MeSH D12.776.377.715.548.114.301.849 – tetanus antitoxin MeSH D12.776.377.715.548.114.323 – autoantibodies MeSH D12.776.377.715.548.114.323.190 – antibodies, antineutrophil cytoplasmic MeSH D12.776.377.715.548.114.323.204 – antibodies, antinuclear MeSH D12.776.377.715.548.114.323.210 – antibodies, antiphospholipid MeSH D12.776.377.715.548.114.323.210.100 – antibodies, anticardiolipin MeSH D12.776.377.715.548.114.323.210.600 – lupus coagulation inhibitor MeSH D12.776.377.715.548.114.323.300 – complement c3 nephritic factor MeSH D12.776.377.715.548.114.323.390 – immunoconglutinins MeSH D12.776.377.715.548.114.323.480 – immunoglobulins, thyroid-stimulating MeSH D12.776.377.715.548.114.323.480.500 – long-acting thyroid stimulator MeSH D12.776.377.715.548.114.323.732 – rheumatoid factor MeSH D12.776.377.715.548.114.345 – binding sites, antibody MeSH D12.776.377.715.548.114.345.180 – complementarity determining regions MeSH D12.776.377.715.548.114.525 – hemolysins MeSH D12.776.377.715.548.114.573 – immune sera MeSH D12.776.377.715.548.114.573.203 – antilymphocyte serum MeSH D12.776.377.715.548.114.580 – immunoconjugates MeSH D12.776.377.715.548.114.580.450 – immunotoxins MeSH D12.776.377.715.548.114.606 – immunoglobulin allotypes MeSH D12.776.377.715.548.114.606.586 – immunoglobulin gm allotypes MeSH D12.776.377.715.548.114.606.587 – immunoglobulin km allotypes MeSH D12.776.377.715.548.114.619 – immunoglobulin isotypes MeSH D12.776.377.715.548.114.619.026 – immunoglobulin a MeSH D12.776.377.715.548.114.619.026.030 – immunoglobulin a, secretory MeSH D12.776.377.715.548.114.619.026.030.500 – secretory component MeSH D12.776.377.715.548.114.619.026.515 – immunoglobulin alpha-chains MeSH D12.776.377.715.548.114.619.251 – immunoglobulin d MeSH D12.776.377.715.548.114.619.251.500 – immunoglobulin delta-chains MeSH D12.776.377.715.548.114.619.312 – immunoglobulin e MeSH D12.776.377.715.548.114.619.312.500 – immunoglobulin epsilon-chains MeSH D12.776.377.715.548.114.619.393 – immunoglobulin g MeSH D12.776.377.715.548.114.619.393.522 – immunoglobulin gamma-chains MeSH D12.776.377.715.548.114.619.393.522.400 – immunoglobulin gm allotypes MeSH D12.776.377.715.548.114.619.393.550 – long-acting thyroid stimulator MeSH D12.776.377.715.548.114.619.393.570 – muromonab-cd3 MeSH D12.776.377.715.548.114.619.393.700 – rho(d) immune globulin MeSH D12.776.377.715.548.114.619.574 – immunoglobulin m MeSH D12.776.377.715.548.114.619.574.500 – immunoglobulin mu-chains MeSH D12.776.377.715.548.114.632 – immunoglobulins, intravenous MeSH D12.776.377.715.548.114.648 – immunoglobulins, thyroid-stimulating MeSH D12.776.377.715.548.114.656 – insulin antibodies MeSH D12.776.377.715.548.114.664 – isoantibodies MeSH D12.776.377.715.548.114.715 – oligoclonal bands MeSH D12.776.377.715.548.114.767 – opsonin proteins MeSH D12.776.377.715.548.114.820 – plantibodies MeSH D12.776.377.715.548.114.837 – precipitins MeSH D12.776.377.715.548.114.890 – reagins MeSH D12.776.377.715.548.397 – gamma-globulins MeSH D12.776.377.715.548.397.500 – tuftsin MeSH D12.776.377.715.548.538 – immunoglobulin constant regions MeSH D12.776.377.715.548.538.249 – immunoglobulin fab fragments MeSH D12.776.377.715.548.538.500 – immunoglobulin fc fragments MeSH D12.776.377.715.548.538.500.249 – cd4 immunoadhesins MeSH D12.776.377.715.548.680 – immunoglobulin fragments MeSH D12.776.377.715.548.680.650 – immunoglobulin fab fragments MeSH D12.776.377.715.548.680.650.500 – immunoglobulin variable region MeSH D12.776.377.715.548.680.650.500.180 – complementarity determining regions MeSH D12.776.377.715.548.680.650.500.590 – immunoglobulin joining region MeSH D12.776.377.715.548.680.650.750 – tuftsin MeSH D12.776.377.715.548.680.660 – immunoglobulin fc fragments MeSH D12.776.377.715.548.680.660.249 – cd4 immunoadhesins MeSH D12.776.377.715.548.680.660.500 – immunoglobulin constant regions MeSH D12.776.377.715.548.680.745 – immunoglobulin idiotypes MeSH D12.776.377.715.548.705 – immunoglobulin subunits MeSH D12.776.377.715.548.705.500 – immunoglobulin heavy chains MeSH D12.776.377.715.548.705.500.350 – immunoglobulin alpha-chains MeSH D12.776.377.715.548.705.500.360 – immunoglobulin delta-chains MeSH D12.776.377.715.548.705.500.370 – immunoglobulin epsilon-chains MeSH D12.776.377.715.548.705.500.380 – immunoglobulin gamma-chains MeSH D12.776.377.715.548.705.500.380.500 – immunoglobulin gm allotypes MeSH D12.776.377.715.548.705.500.500 – immunoglobulin mu-chains MeSH D12.776.377.715.548.705.625 – immunoglobulin j-chains MeSH D12.776.377.715.548.705.750 – immunoglobulin light chains MeSH D12.776.377.715.548.705.750.530 – immunoglobulin kappa-chains MeSH D12.776.377.715.548.705.750.530.500 – immunoglobulin km allotypes MeSH D12.776.377.715.548.705.750.550 – immunoglobulin lambda-chains MeSH D12.776.377.715.548.705.875 – secretory component MeSH D12.776.377.715.548.797 – immunoglobulin variable region MeSH D12.776.377.715.548.797.180 – complementarity determining regions MeSH D12.776.377.715.548.797.570 – immunoglobulin fab fragments MeSH D12.776.377.715.548.797.590 – immunoglobulin joining region MeSH D12.776.377.715.548.900 – paraproteins MeSH D12.776.377.715.548.900.120 – bence jones protein MeSH D12.776.377.715.548.900.225 – cryoglobulins MeSH D12.776.377.715.548.900.500 – myeloma proteins MeSH D12.776.377.715.548.900.700 – pyroglobulins MeSH D12.776.377.715.548.950 – receptors, antigen, b-cell MeSH D12.776.377.715.548.950.500 – antigens, cd79
Fentanyl's most common side effects, which affect more than 10% of people, include nausea, vomiting, constipation, dry mouth, somnolence, confusion, and asthenia (weakness). Less frequently, in 3–10% of people, fentanyl can cause abdominal pain, headache, fatigue, anorexia and weight loss, dizziness, nervousness, anxiety, depression, flu-like symptoms, dyspepsia (indigestion), shortness of breath, hypoventilation, apnea, and urinary retention. Fentanyl use has also been associated with aphasia. Despite being a more potent analgesic, fentanyl tends to induce less nausea, as well as less histamine-mediated itching, than morphine. In rare cases, serotonin syndrome is associated with fentanyl use. Existing studies advise medical practitioners to exercise caution when combining selective serotonin reuptake inhibitor (SSRI) drugs with fentanyl. The duration of action of fentanyl has sometimes been underestimated, leading to harm in a medical context. In 2006, the United States Food and Drug Administration (FDA) began investigating several respiratory deaths, but doctors in the United Kingdom were not warned of the risks with fentanyl until September 2008. The FDA reported in April 2012 that twelve young children had died and twelve more had become seriously ill from separate accidental exposures to fentanyl skin patches.
== Awards and honors == 2024 York U Alumni Award for Outstanding Achievement 2020 Lifetime Achievement Award in Plasma Spectrochemistry 2019 HUPO Award (Human Proteome Organization) 2014 Fellow of the American Institute for Medical and Biological Engineering 2011 University of Toronto Inventor of the Year Award for Biomedical and Life Sciences 2011 Thermo Fisher Scientific Spectroscopy Award 2004 Elsevier / Spectrochimica Acta Atomic Spectroscopy Award for the most important paper published in Spectrochimica Acta Part B in 2002 (Title: Reaction cells and collision cells for ICP-MS: a tutorial review) in co-authorship with Dmitry Bandura and Vladimir Baranov 2003 W.A.E. McBryde medal from the Canadian Chemical Society of the Chemical Institute of Canada 2001 Manning Innovation Award, Award of Distinction Dr. Scott Tanner, together with Dr. Vladimir Baranov, received the Manning Award of Distinction from the Manning Innovation Awards Foundation for the remarkable invention of the ICP-MS Dynamic Reaction Cell (Collision/reaction cell). 1999 Pittcon Editors' Awards Perkin-Elmer Sciex for their ELAN 6100 DRC (Dynamic Reaction Cell) ICP-MS system. Fellow of the Royal Society of Chemistry (UK) Fellow of the American Institute for Medical and Biological Engineering (AIMBE)
It also suppresses the norepinephrine-induced increase in the sarcoplasmic reticulum (SR) Ca2+ leak and the spontaneous SR Ca2+ release, which are the major triggers for atrial fibrillation. Through this mechanism of selective blockade at β1 receptors, metoprolol exerts the following effects:
The initiative was a response to far-reaching developments in community values since Censorship of Publications legislation was recommended by the Committee on Evil Literature, established in 1926. Modern laws will continue to allow control of indecent or obscene publications, including child abuse material, while permitting information on contraception, abortion and divorce. 23 November – A five-year-old girl and a woman in her 30s were seriously injured, and three others hurt, in a mass stabbing outside a primary school in Parnell Square East, Dublin. Following the knife attack, a riot took place in Dublin city centre, in which Gardaí and civilians were attacked, Garda vehicles, four Dublin Buses and a Luas tram set alight, and projectiles and fireworks were thrown at Gardaí. 24 November – Latest figures showed that homelessness hit new records: 9,188 adults and 3,991 children accessed emergency accommodation in October 2023, bringing the total to 13,179 people. 25 November – The nine-year-old Irish-Israeli girl, Emily Hand, was released from captivity by Hamas and reunited with her father after being held hostage in Palestine for 50 days. Taoiseach Varadkar and Tánaiste Martin welcomed the news. 26 November Singer Jessica McKean represented Ireland in the Junior Eurovision Song Contest 2023, alongside Sophie Lennon, the Irish representative of the previous year, with the song "Aisling". Irish author Paul Lynch won the 2023 Booker Prize with his dystopian novel Prophet Song. Phase 5b of the BusConnects transport infrastructure programme was launched in Dublin
Sources: en.wikipedia.org
Degree of hydrolysis is often estimated by quantifying free amino groups or by titrating cleaved peptide bonds. It can also be inferred from molecular weight distribution using chromatography. Values are operationally defined, so comparisons require the same method and conditions.
Hydrolysis can expose hydrophobic amino acid regions that interact with bitterness receptors. The intensity depends on enzyme specificity, peptide size, and the degree of hydrolysis. Further processing or masking agents may reduce perceived bitterness.
Not necessarily. Extensively hydrolyzed products may have reduced allergenicity, but partial hydrolysates can retain IgE-reactive peptides, so the word hydrolyzed alone does not establish safety for milk allergy. Safety depends on product-specific testing and clinical evaluation.
Degree of hydrolysis is commonly estimated by quantifying free amino groups with colorimetric assays such as o-phthaldialdehyde or trinitrobenzenesulfonic acid. The result is expressed as a percentage of total peptide bonds cleaved. Because different assays can give different values, method details matter when comparing products.